Recent VTRS News
- Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline • PR Newswire (US) • 03/27/2024 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:29:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:24:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:09:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:54:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:47:44 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:26:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:11:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:39:17 PM
- Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance • PR Newswire (US) • 02/28/2024 11:30:00 AM
- Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration • PR Newswire (US) • 02/28/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:00:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 10:18:00 PM
- Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results • PR Newswire (US) • 02/05/2024 11:59:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/30/2024 09:40:59 PM
- Viatris recognised as a Top Employer 2024 in the UK for the second consecutive year • PR Newswire (US) • 01/19/2024 11:56:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 11:00:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/05/2024 01:28:15 AM
- Viatris to Participate in 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/21/2023 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 11:00:06 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/15/2023 10:04:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 10:00:53 PM
- Viatris Continues its Preparations for Phase 2 of its Strategic Plan by Announcing the Appointment of Theodora "Doretta" Mistras as Chief Financial Officer, Effective March 1, 2024, and Philippe Martin as Chief R&D Officer • PR Newswire (US) • 12/15/2023 09:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 09:14:31 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM